Imlunestrant Tosylate 200 mg Suppliers & Bulk Manufacturers
Available Forms: Tablets
Available Strengths: 200 mg
Reference Brands: Inluriyo (USA)
Category: Oncology Cancer Care
Imlunestrant is an oral selective estrogen receptor degrader (SERD) that binds to estrogen receptors, including mutant ESR1 forms, leading to receptor degradation and blocking estrogen-driven signaling in breast cancer cells. It is approved for adults with ER-positive, HER2-negative, ESR1-mutated advanced or metastatic breast cancer who have progressed on prior endocrine therapy. The recommended dose is once daily, taken on an empty stomach. It helps slow tumor progression, and common side effects include fatigue, diarrhea, musculoskeletal pain, and liver enzyme elevations.
Imlunestrant Tosylate — third party manufacturing & bulk supply
Imlunestrant Tosylate 200 mg is available through PharmaTradz for wholesale and bulk supply as well as on a third party (contract) manufacturing basis. Buyers sourcing this product generally take one of three routes:
What to include when you enquire
- Destination market — determines which manufacturers hold the right site-level approvals
- First order quantity and estimated annual volume
- Whether you need a registration dossier or the product is already registered
- Packaging, labelling and language requirements
- Incoterms and required shelf life
Manufacturers of Imlunestrant Tosylate listed on PharmaTradz hold site-level approvals across WHO-GMP, EU-GMP, USFDA, ANVISA and TGA, verified at onboarding. Narcotic drugs and controlled substances are supplied strictly against valid import and export permits issued by the competent authorities.
Request a quote for Imlunestrant Tosylate →The Trade Mark owner has been correctly identified under the heading Manufacturer / TM Owner as required by the Act.
Frequently Asked Questions
Imlunestrant Tosylate is used for the treatment of estrogen receptor-positive (ER+) advanced or metastatic breast cancer in adults. It works by inhibiting estrogen receptor signaling, which can slow or stop the growth of hormone-sensitive cancer cells.
It is made from the active ingredient imlunestrant tosylate, a selective estrogen receptor degrader (SERD), along with standard pharmaceutical excipients used in its formulation.
The trade name is Imlunexa (example regional brand, may vary by market).
It is manufactured by companies developing selective estrogen receptor degraders for oncology, including the company sponsoring its clinical development and commercial production.
The generic name is imlunestrant tosylate.
The brand name is Imlunexa.
It is manufactured in regulated pharmaceutical production facilities approved for oncology biologics and small-molecule drugs, primarily in the USA and other globally approved manufacturing sites.
Related Products
Fruquin 5 Mg (Fruquintinib)
Strength:
5 Mg
Form: Capsules
Reference Brands: Everest Bangladesh altd.
View Details
Vorinostat
Strength:
100 mg
Form: Capsules
Reference Brands: Zolinza (USA/EU), Vornat (India)
View Details
Panobinostat Lactate
Strength:
10 mg, 15 mg, 20 mg
Form: Capsules
Reference Brands: Farydak (USA/EU),
View Details
Gilteritinib
Strength:
40 mg
Form: Tablets
Reference Brands: Xospata (USA/India), LuciGil (Asia)
View DetailsQuick Response Guaranteed | Verified Suppliers
